Welcome to our dedicated page for Inmode news (Ticker: INMD), a resource for investors and traders seeking the latest updates and insights on Inmode stock.
InMode Ltd. reports developments in medical-technology devices that use radiofrequency technology for minimally invasive and non-invasive aesthetic and medical procedures. Company updates commonly address product platforms and treatment categories for plastic surgery, dermatology, gynecology, otolaryngology and ophthalmology, including face and body contouring, medical aesthetics and women's health.
Recurring news also covers GAAP and non-GAAP financial results, consumables and service revenue, regional performance in the United States and Europe, margin trends, investor-conference participation, board-reviewed strategic matters and capital allocation actions such as ordinary-share repurchase programs.
InMode (Nasdaq: INMD) announced that CEO Moshe Mizrahy and CFO Yair Malca will present at the 25th Annual Needham Virtual Healthcare Conference on Monday, April 13, 2026, at 11:00 AM Eastern Time. The session is a fireside chat moderated by Michael Matson.
A live webcast of the presentation will be available and InMode will hold virtual one-on-one investor meetings the same day; scheduling is via Needham representatives and additional event details are on the company's investor relations site.
InMode (Nasdaq: INMD) on March 13, 2026 authorized a new share repurchase program for up to approximately 10% of shares outstanding (about 6.38 million ordinary shares). The company said it repurchased roughly $127.4 million of shares in 2025 and expects to fund repurchases with available cash.
Repurchases may occur in the open market or by other permitted means, are subject to market and legal conditions, and the program may be modified, suspended, or discontinued at the company's discretion.
InMode (Nasdaq: INMD) will present at two investor conferences in March 2026: Barclays 28th Annual Global Healthcare Conference and Oppenheimer 36th Annual Healthcare MedTech & Services Conference.
Presenters: Yair Malca, CFO (Barclays); Moshe Mizrahy, CEO, and Yair Malca, CFO (Oppenheimer). Webcasts are scheduled for March 11 and March 16.
InMode (Nasdaq: INMD) announced that its Board's independent transaction committee has completed a review of proposals for a potential transaction and determined that none of the final proposals was adequate or in shareholders' best interests.
The Committee has discontinued the process; the company will continue to evaluate business and cash allocation strategies to enhance long-term shareholder value and does not intend further updates unless appropriate or required.
InMode (Nasdaq: INMD) reported Q4 2025 GAAP revenue of $103.9 million (+6% vs. Q4 2024) and full‑year 2025 revenue of $370.5 million (‑6% vs. 2024). GAAP net income was $27.0M in Q4 and $93.8M for FY 2025. Cash and marketable securities totaled $555.3M at year‑end. The company repurchased $127.4M of shares in 2025. Management expects 2026 revenue of $365M–$375M and non‑GAAP diluted EPS of $1.43–$1.48. Non‑GAAP measures exclude share‑based compensation and tax benefit adjustments.
InMode (Nasdaq: INMD) will participate in the 13th Annual BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference in Snowbird, UT. Yair Malca, Chief Financial Officer, will host investor meetings on Wednesday, February 11, 2026. Interested investors should contact their BTIG salesperson to schedule a meeting and may visit InMode's investor relations site for event details.
InMode (NASDAQ: INMD) said it is aware of market speculation, including a non-binding proposal by Steel Partners to acquire 51% of outstanding shares, and confirmed it is evaluating strategic alternatives.
The company formed an independent directors' committee, retained independent legal and financial advisors, and said there is no assurance a transaction will occur or on timing or terms.
Steel Partners Holdings offered to buy 51% of InMode (NASDAQ: INMD) at $18.00 per share, a 29% premium to the unaffected January 23, 2026 price. Steel says the offer is fully funded with no financing contingency and cites weak TSR, high cash balances, and repeated guidance cuts.
InMode (Nasdaq: INMD) expects to release fourth-quarter and full-year 2025 results before market open on February 10, 2026 and will hold a conference call the same day at 8:30 a.m. ET. Management provided preliminary, subject-to-adjustment ranges: Q4 2025 revenue $103.6M–$103.8M; FY2025 revenue $370.2M–$370.4M; FY2025 non-GAAP gross margin 78%–79%. The company also provided FY2026 revenue guidance $365M–$375M. Speakers will include CEO Moshe Mizrahy, CFO Yair Malca and CTO Michael Kreindel. A live webcast and replay will be available; preregistration is offered for dial-in access.
InMode (NASDAQ: INMD) reported Q3 2025 GAAP revenue of $93.2M, down from $130.2M in Q3 2024 (which included $31.9M of pre-order sales). GAAP and non-GAAP gross margin was 78%. GAAP net income was $21.9M ($0.34 diluted EPS) and non-GAAP net income was $24.5M ($0.38 diluted EPS). Cash and marketable securities totaled $532.3M as of September 30, 2025. Management reaffirmed full‑year 2025 guidance: revenues of $365M–$375M, non‑GAAP gross margin 78%–80%, non‑GAAP operating income $93M–$98M, and non‑GAAP EPS $1.55–$1.59. Company noted cautious consumer demand and named Michael Dennison president of North America.